[go: up one dir, main page]

AU5628380A - Heterocyclic urea derivatives - Google Patents

Heterocyclic urea derivatives

Info

Publication number
AU5628380A
AU5628380A AU56283/80A AU5628380A AU5628380A AU 5628380 A AU5628380 A AU 5628380A AU 56283/80 A AU56283/80 A AU 56283/80A AU 5628380 A AU5628380 A AU 5628380A AU 5628380 A AU5628380 A AU 5628380A
Authority
AU
Australia
Prior art keywords
urea derivatives
heterocyclic urea
heterocyclic
derivatives
urea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56283/80A
Inventor
Walter Hunkeler
Emilio Kyburz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU5628380A publication Critical patent/AU5628380A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU56283/80A 1979-03-14 1980-03-07 Heterocyclic urea derivatives Abandoned AU5628380A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH241579 1979-03-14
CH241579 1979-03-14
CH17180 1980-01-10
CH17180 1980-01-10

Publications (1)

Publication Number Publication Date
AU5628380A true AU5628380A (en) 1980-09-18

Family

ID=25683737

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56283/80A Abandoned AU5628380A (en) 1979-03-14 1980-03-07 Heterocyclic urea derivatives

Country Status (10)

Country Link
EP (1) EP0016371A1 (en)
AU (1) AU5628380A (en)
DK (1) DK108780A (en)
ES (1) ES489493A0 (en)
FI (1) FI800559A7 (en)
GR (1) GR66630B (en)
IL (1) IL59563A0 (en)
MC (1) MC1317A1 (en)
NO (1) NO800720L (en)
PT (1) PT70949B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
WO2000042012A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
RU2319693C9 (en) 1999-01-13 2008-08-20 Байер Копэрейшн Derivatives of urea (variants), pharmaceutical composition (variants) and method for treatment of diseases associated with cancer cells growth (variants)
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
ES2377847T3 (en) 1999-01-13 2012-04-02 Bayer Healthcare Llc Diphenyl ureas substituted with omega-carboxy aryl as kinase inhibitors p38
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
US20030216396A1 (en) 2002-02-11 2003-11-20 Bayer Corporation Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
PT1580188E (en) 2002-02-11 2012-01-25 Bayer Healthcare Llc Aryl ureas as kinase inhibitors
EP1478358B1 (en) 2002-02-11 2013-07-03 Bayer HealthCare LLC Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
ES2288694T3 (en) 2003-05-20 2008-01-16 Bayer Pharmaceuticals Corporation DIARIL UREAS FOR DISEASES MEDIATED BY THE RECEIVER OF THE GROWTH FACTOR DERIVED FROM PLATES.
KR101139557B1 (en) 2003-07-23 2012-04-30 바이엘 파마슈티칼스 코포레이션 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
MXPA06012394A (en) 2004-04-30 2007-01-31 Bayer Pharmaceuticals Corp Substituted pyrazolyl urea derivatives useful in the treatment of cancer.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2448869A1 (en) * 1973-10-19 1975-09-04 Mcneilab Inc 4-OXO-2-IMIDAZOLIDINYLIDEN UREMENTS, THE METHOD OF MANUFACTURING THEREOF AND MEDICINAL PRODUCTS
US3983135A (en) * 1974-09-23 1976-09-28 Mcneil Laboratories, Incorporated 4-Oxo-2-imidazolidinylidene ureas
US4025517A (en) * 1975-06-23 1977-05-24 Mcneil Laboratories, Incorporated 4-Oxo-2-hexahydropyrimidinylidene ureas

Also Published As

Publication number Publication date
NO800720L (en) 1980-09-15
ES8103737A1 (en) 1981-03-16
IL59563A0 (en) 1980-06-30
GR66630B (en) 1981-04-03
EP0016371A1 (en) 1980-10-01
FI800559A7 (en) 1981-01-01
PT70949A (en) 1980-04-01
PT70949B (en) 1981-06-24
DK108780A (en) 1980-09-15
MC1317A1 (en) 1981-03-10
ES489493A0 (en) 1981-03-16

Similar Documents

Publication Publication Date Title
AU544313B2 (en) Guanidine derivatives
AU6438480A (en) Guanidine derivatives
AU533566B2 (en) Aminoalkylbenzene derivatives
AU538841B2 (en) Quindine derivatives
AU551161B2 (en) Urea derivatives
AU542537B2 (en) Nor-tropane derivatives
AU544515B2 (en) Heterocyclic amino acid derivatives
AU535979B2 (en) 2-imidazoline derivatives
AU529742B2 (en) Alkyl-ketohexopyranoside derivatives
AU516325B2 (en) Spiro-imidazolidinedione derivatives
AU5628380A (en) Heterocyclic urea derivatives
AU534806B2 (en) 3-vinyl-cephalosporin derivatives
AU538138B2 (en) Methylene-cycloamine derivatives
AU533797B2 (en) Thioethylamide derivatives
ZA801151B (en) Heterocyclic derivatives
AU520245B2 (en) Glycerylphosphoryl derivatives
AU526214B2 (en) Pteridin derivatives
AU538139B2 (en) 3-methyleneazetidine derivatives
AU530761B2 (en) Halo-vincamone derivatives
GB2046255B (en) Urea derivatives
AU522936B2 (en) Urea derivatives
AU533484B2 (en) Tetrahydrochinoline derivatives
AU538087B2 (en) Halophenyl-pyridyl - allylamine derivatives
AU538028B2 (en) 1-oxadethiacephalosporin derivatives
AU5515380A (en) Benzamidine derivatives